AbbVie and Amgen are two great stocks that are way too cheap right now. The stock market's recent volatility shouldn't concern investors with a long-term outlook. In fact, it's probably
Snapmay no longer be the laughing stock of the New York Stock Exchange.
On the heels of renewed user growth and an earnings beat, Snap closed Wednesday with a share price at $17.60, up 18.68% for the day, giving the company its first close above its $17 IPO debut price since March of last year.
After a highly anticipated debut sent Snap’s share price climbing 44% on its first day of trading in March of 2017, the company’s stock soon plummeted as its first earnings report detailed slowed user growth that would continue for the next several periods. It was only a few months later that the company’s stock dipped below its $17 debut share price, a number it briefly rose above in early 2018 before sinking to an all-time low of $4.82 in late December.
The company’s earnings report yesterday may signify a turning point for the social media company that has reportedly struggled to retain executive and engineering talent in recent months in the face of rapidly declining investor enthusiasm. In the company’s Q2 earnings report, Snap executives highlighted their strengths as they highlighted a 13 million quarter-over-quarter increase in daily active users and a command over